Cargando…
Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity
Dynamically adapting the allocation of COVID-19 vaccines to the evolving epidemiological situation could be key to reduce COVID-19 burden. Here we developed a data-driven mechanistic model of SARS-CoV-2 transmission to explore optimal vaccine prioritization strategies in China. We found that a time-...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333090/ https://www.ncbi.nlm.nih.gov/pubmed/34344871 http://dx.doi.org/10.1038/s41467-021-24872-5 |
_version_ | 1783732965249908736 |
---|---|
author | Han, Shasha Cai, Jun Yang, Juan Zhang, Juanjuan Wu, Qianhui Zheng, Wen Shi, Huilin Ajelli, Marco Zhou, Xiao-Hua Yu, Hongjie |
author_facet | Han, Shasha Cai, Jun Yang, Juan Zhang, Juanjuan Wu, Qianhui Zheng, Wen Shi, Huilin Ajelli, Marco Zhou, Xiao-Hua Yu, Hongjie |
author_sort | Han, Shasha |
collection | PubMed |
description | Dynamically adapting the allocation of COVID-19 vaccines to the evolving epidemiological situation could be key to reduce COVID-19 burden. Here we developed a data-driven mechanistic model of SARS-CoV-2 transmission to explore optimal vaccine prioritization strategies in China. We found that a time-varying vaccination program (i.e., allocating vaccines to different target groups as the epidemic evolves) can be highly beneficial as it is capable of simultaneously achieving different objectives (e.g., minimizing the number of deaths and of infections). Our findings suggest that boosting the vaccination capacity up to 2.5 million first doses per day (0.17% rollout speed) or higher could greatly reduce COVID-19 burden, should a new wave start to unfold in China with reproduction number ≤1.5. The highest priority categories are consistent under a broad range of assumptions. Finally, a high vaccination capacity in the early phase of the vaccination campaign is key to achieve large gains of strategic prioritizations. |
format | Online Article Text |
id | pubmed-8333090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83330902021-08-12 Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity Han, Shasha Cai, Jun Yang, Juan Zhang, Juanjuan Wu, Qianhui Zheng, Wen Shi, Huilin Ajelli, Marco Zhou, Xiao-Hua Yu, Hongjie Nat Commun Article Dynamically adapting the allocation of COVID-19 vaccines to the evolving epidemiological situation could be key to reduce COVID-19 burden. Here we developed a data-driven mechanistic model of SARS-CoV-2 transmission to explore optimal vaccine prioritization strategies in China. We found that a time-varying vaccination program (i.e., allocating vaccines to different target groups as the epidemic evolves) can be highly beneficial as it is capable of simultaneously achieving different objectives (e.g., minimizing the number of deaths and of infections). Our findings suggest that boosting the vaccination capacity up to 2.5 million first doses per day (0.17% rollout speed) or higher could greatly reduce COVID-19 burden, should a new wave start to unfold in China with reproduction number ≤1.5. The highest priority categories are consistent under a broad range of assumptions. Finally, a high vaccination capacity in the early phase of the vaccination campaign is key to achieve large gains of strategic prioritizations. Nature Publishing Group UK 2021-08-03 /pmc/articles/PMC8333090/ /pubmed/34344871 http://dx.doi.org/10.1038/s41467-021-24872-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Han, Shasha Cai, Jun Yang, Juan Zhang, Juanjuan Wu, Qianhui Zheng, Wen Shi, Huilin Ajelli, Marco Zhou, Xiao-Hua Yu, Hongjie Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity |
title | Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity |
title_full | Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity |
title_fullStr | Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity |
title_full_unstemmed | Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity |
title_short | Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity |
title_sort | time-varying optimization of covid-19 vaccine prioritization in the context of limited vaccination capacity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333090/ https://www.ncbi.nlm.nih.gov/pubmed/34344871 http://dx.doi.org/10.1038/s41467-021-24872-5 |
work_keys_str_mv | AT hanshasha timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT caijun timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT yangjuan timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT zhangjuanjuan timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT wuqianhui timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT zhengwen timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT shihuilin timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT ajellimarco timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT zhouxiaohua timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity AT yuhongjie timevaryingoptimizationofcovid19vaccineprioritizationinthecontextoflimitedvaccinationcapacity |